Medical Director at SMB
High Openness and Extraversion to lead medical-scientific strategy, represent the company before agencies, and build clinical positioning.
In SMB pharma, quality and compliance are the license to operate
The development pipeline is the company's valuation and main asset
The relationship with local health authorities is capital built over years
Ideal OCEAN+ Profile
At SMBs (51-200 employees), strategic scientific vision to design the evidence plan, lead advisory boards, and anticipate the medical landscape that will impact the portfolio
At SMBs (51-200 employees), rigor in validating shared medical information, compliance with reporting obligations, and quality of the evidence strategy
At SMBs (51-200 employees), executive presence in the C-suite, leadership of medical teams, and representation of the company before KOLs, agencies, and academia
At SMBs (51-200 employees), cross-functional influence over commercial, regulatory, and access teams to align medical strategy with business needs
At SMBs (51-200 employees), handling safety crises, public scientific controversies, and business performance pressure that demand difficult medical-ethical decisions
At SMBs (51-200 employees), the Medical Director alternates between medical process governance and scientific exploration; needs comfort with regulatory frameworks without structure preventing adjustments to the evidence plan when the clinical landscape shifts
Strengths and Red Flags
Strengths
- Design of clinical evidence strategy that positions the portfolio in treatment guidelines
- Scientific representation of the company before KOLs, agencies, and public health bodies
- Managing development pipelines balancing innovation with commercial viability
- GMP and regulatory compliance with limited internal quality teams
Red Flags
- Subordinating scientific objectivity to commercial business pressures
- Disconnection from the real clinical environment, generating medical strategies that physicians do not adopt
- Difficulty maintaining compliance with limited quality resources
- Resists outsourcing activities it can't perform internally
Interview Questions
Describe the most complex evidence strategy you designed. How did you balance scientific needs with the business's timelines and resources?
Evaluates: Strategic Openness and ability to balance science with business
The commercial team wants to position a subgroup finding that is statistically significant but clinically questionable. What position do you take and how do you communicate it internally?
Evaluates: Conscientiousness and medical-scientific integrity under commercial pressure
How did you maintain GMP compliance with limited quality teams?
Evaluates: Conscientiousness and efficiency in quality management
How did you balance innovation with commercial viability in your pipeline?
Evaluates: Balance between scientific rigor and business pragmatism
More about Medical Director
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Medical Director — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → Enterprise (201-1000 employees)In enterprise pharma, multi-market regulatory complexity is the norm
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Medical Director at SMB (51-200 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card